Company Monitoring Page for JNJ

latest headlines for company on cafepharma

In a crowded market, AbbVie may still have a best-in-class psoriasis prospect up its sleeve: analyst
Fierce Pharma
Wed, 12/6/17 - 09:53 am
Tags:
AbbVie, psoriasis, risankizumab, JNJ, Tremfya
J&J, Sanofi ranked best for clinical trial transparency
BioPharma Dive
Wed, 12/6/17 - 09:43 am
Tags:
JNJ, Sanofi, clinical trials, transparency, clinical trial data
As Johnson & Johnson holds off U.S. biosims, Remicade's European market share falls to 50%: report
Fierce Pharma
Tue, 12/5/17 - 06:31 pm
Tags:
JNJ, biosimilars, Remicade, Europe, anti-TNF
J&J, Bayer lose first Xarelto bleeding case, hit with $28M verdict
Fierce Pharma
Tue, 12/5/17 - 06:30 pm
Tags:
JNJ, Bayer, Xarelto, bloodthinners
Will 2018 Be Johnson & Johnson's Best Year Yet?
Motley Fool
Mon, 12/4/17 - 10:02 pm
Tags:
JNJ
Pfizer tops Dow's intellectual heap, with J&J and Merck close behind: study
Fierce Pharma
Mon, 12/4/17 - 11:45 am
Tags:
Pfizer, JNJ, Merck
J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
Endpoints
Mon, 12/4/17 - 11:43 am
Tags:
JNJ, hypertension, Idorsia, Actelion
J&J-led coalition launches a landmark efficacy study for an HIV mosaic vaccine
Endpoints
Thu, 11/30/17 - 09:46 am
Tags:
JNJ, HIV, vaccines, R&D, mosaic vaccine, Imbokodo, HVTN 705/HPX2008
Genmab and J&J 'love' partnership as some ponder takeover
Yahoo/Reuters
Thu, 11/30/17 - 09:42 am
Tags:
Genmab, JNJ, M&A, Darzalex
Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo
Fierce Pharma
Tue, 11/28/17 - 09:05 pm
Tags:
GSK, cabotegravir, HIV, Endurant, ViiV, JNJ, Janssen
Pelvic mesh jury to decide if device is 'defective' and whether J&J should pay
NorthJersey.com
Tue, 11/28/17 - 09:49 am
Tags:
JNJ, pelvic mesh, devices
J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space
Yahoo/Zacks.com
Sat, 11/25/17 - 12:39 pm
Tags:
JNJ, GSK, Jucala, HIV
J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits
Fierce Pharma
Fri, 11/24/17 - 09:23 am
Tags:
JNJ, Eli Lilly, AstraZeneca, Boehringer Ingelheim, diabetes, Invokana, Farxiga, Jardiance
J&J multiple myeloma drug succeeds in first-line combination study
Yahoo/Reuters
Tue, 11/21/17 - 09:50 am
Tags:
JNJ, Multiple Myeloma, clinical trials, Darzalex
How JNJ’s Medical Devices Business Restructuring Efforts Are Panning Out
Market Realist
Sat, 11/18/17 - 09:44 am
Tags:
JNJ, devices, restructuring
J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial
Mass Device
Sat, 11/18/17 - 09:33 am
Tags:
JNJ, DePuy Ortho, Pinnacle Hip, hip implants, devices
J&J notches latest win in long-running talc saga as caseload grows to 5,500
Fierce Pharma
Fri, 11/17/17 - 10:24 am
Tags:
JNJ
J&J goes back to Ionis for its second experimental pill for a GI autoimmune disease
Endpoints
Thu, 11/16/17 - 11:08 am
Tags:
JNJ, Ionis Pharmaceuticals, autoimmune disease, IONIS-JBI2-2.5Rx, antisense
J&J's Xarelto pads artery disease case by reducing amputation, death rates vs. aspirin
Fierce Pharma
Thu, 11/16/17 - 09:41 am
Tags:
JNJ, Xarelto, blood thinners, PAD, coronary artery disease
J&J antes $50M to get Zymeworks’ 6th big bispecifics alliance underway, with $6B in total milestones on the table
Endpoints
Mon, 11/13/17 - 09:16 am
Tags:
JNJ, Zymeworks, drug development, bispecific antibodies

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.